Guided Therapeutics Inc (GTHP) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
5835 PEACHTREE CORNERS EAST PEACHTREE CORNERS, GA 30092 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 2,313 | 2,697 | 446 | 725 | 643 | 541 | 922 | ||
| Cash and cash equivalents | 2,313 | 2,697 | 446 | 725 | 643 | 541 | 922 | ||
| Receivables | 6 | 78 | 155 | 165,000 | 172 | 149,000 | 152,000 | ||
| Inventory, net of allowances, customer advances and progress billings | 548 | 596 | 569 | 570 | 571 | 590 | 631 | ||
| Inventory | 548 | 596 | 569 | 570 | 571 | 590 | 631 | ||
| Other current assets | 137 | 169 | 59 | 453 | 377 | 173 | 61 | ||
| Other undisclosed current assets | (49) | (126) | (164,961) | (126) | (148,976) | (151,974) | |||
| Total current assets: | 3,004 | 3,491 | 1,103 | 1,787 | 1,637 | 1,328 | 1,640 | ||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 303 | 321 | 338 | 355 | 372 | 388 | 403 | ||
| Property, plant and equipment | 42 | 42 | 45 | 28 | 14 | 11 | 7 | ||
| Other noncurrent assets | 17 | 17 | 17 | 17 | 17 | 17 | 17 | ||
| Total noncurrent assets: | 362 | 380 | 400 | 400 | 403 | 416 | 427 | ||
| TOTAL ASSETS: | 3,366 | 3,871 | 1,503 | 2,187 | 2,040 | 1,744 | 2,067 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 3,433 | 3,639 | 4,148 | 4,235 | 4,740 | 4,109 | 4,599 | ||
| Interest and dividends payable | ✕ | 372 | 538 | 531 | 610 | 509 | 485 | ||
| Accounts payable | 2,186 | 2,217 | 2,404 | 2,476 | 2,362 | 2,220 | 2,383 | ||
| Accrued liabilities | 1,247 | 1,050 | 1,206 | 1,228 | 1,768 | 1,380 | 1,731 | ||
| Deferred revenue | 509 | 509 | 513 | 514 | 337 | 278 | 62 | ||
| Debt | 132 | 229 | 47 | 79 | 136 | 101 | 24 | ||
| Derivative instruments and hedges, liabilities | 19 | 24 | 38 | ||||||
| Due to related parties | 40 | 497 | 490 | 27 | 87 | 94 | 97 | ||
| Other undisclosed current liabilities | 755 | 253 | 774 | 556 | 394 | 494 | 889 | ||
| Total current liabilities: | 4,869 | 5,146 | 5,996 | 5,449 | 5,694 | 5,076 | 5,671 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 1,046 | 1,284 | 1,171 | 1,159 | 325 | 343 | 357 | ||
| Long-term debt, excluding current maturities | 1,046 | 1,017 | 884 | 852 | |||||
| Liabilities, other than long-term debt | 334 | 92 | 102 | 568 | 624 | 616 | 608 | ||
| Due to related parties | 83 | 92 | 102 | 568 | 592 | 586 | 579 | ||
| Operating lease, liability | 246 | 267 | 287 | 307 | 325 | 343 | 357 | ||
| Derivative instruments and hedges, liabilities | 5 | 32 | 30 | 29 | |||||
| Other undisclosed noncurrent liabilities | 842 | 787 | 755 | ||||||
| Total noncurrent liabilities: | 1,380 | 1,376 | 1,273 | 1,727 | 1,791 | 1,746 | 1,720 | ||
| Total liabilities: | 6,249 | 6,522 | 7,269 | 7,176 | 7,485 | 6,822 | 7,391 | ||
| Temporary equity, carrying amount | 50 | ||||||||
| Equity | |||||||||
| Equity, attributable to parent, including: | (2,883) | (2,651) | (5,766) | (4,989) | (5,445) | (5,078) | (5,324) | ||
| Common stock | 3,437 | 3,432 | 3,416 | 3,410 | 3,403 | 3,403 | 3,403 | ||
| Treasury stock, value | (132) | (132) | (132) | (132) | (132) | (132) | (132) | ||
| Common stock, value, subscriptions | 351 | ||||||||
| Additional paid in capital | 138,090 | 136,366 | 130,166 | 129,042 | 126,800 | 126,650 | 126,353 | ||
| Accumulated deficit | (147,359) | (145,502) | (144,448) | (143,442) | (142,387) | (141,878) | (141,827) | ||
| Other undisclosed equity, attributable to parent | 3,081 | 3,185 | 5,232 | 6,133 | 6,520 | 6,879 | 6,879 | ||
| Total equity: | (2,883) | (2,651) | (5,766) | (4,989) | (5,445) | (5,078) | (5,324) | ||
| Other undisclosed liabilities and equity | (50) | ||||||||
| TOTAL LIABILITIES AND EQUITY: | 3,366 | 3,871 | 1,503 | 2,187 | 2,040 | 1,744 | 2,067 | ||
Income Statement (P&L) ($ in thousands) Annual | Quarterly
| 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 3 | 5 | 5 | 60 | 19 | 2 | ||
| Direct financing lease, revenue | 4,000 | |||||||
| Other income | 11 | 2 | 93 | 387 | 27 | |||
| Cost of revenue | (79) | (1) | (1) | (42) | ||||
| Cost of goods and services sold | (79) | (1) | (1) | |||||
| Other undisclosed gross profit | (19) | |||||||
| Gross profit: | (79) | 3 | 4 | 4 | 41 | (23) | 2 | |
| Operating expenses | (869) | (1,227) | (721) | (447) | (476) | (464) | (563) | |
| Operating loss: | (948) | (1,224) | (717) | (443) | (435) | (487) | (561) | |
| Nonoperating income (expense) (Other Nonoperating Income (Expense)) | (859) | 122 | (209) | (64) | (9) | 555 | (473) | |
| Interest and debt expense | (1,000) | 270 | 34 | 41 | 1,050 | 169 | (315) | |
| Other undisclosed income (loss) from continuing operations before equity method investments, income taxes | 1,000 | (270) | (34) | (41) | (578) | 315 | ||
| Income (loss) from continuing operations: | (1,807) | (1,102) | (926) | (507) | 28 | 237 | (1,034) | |
| Income (loss) before gain (loss) on sale of properties: | ✕ | (1,102) | (926) | (507) | 28 | 237 | (1,034) | |
| Other undisclosed net loss | (472) | (169) | ||||||
| Net income (loss): | (1,807) | (1,102) | (926) | (507) | (444) | 68 | (1,034) | |
| Other undisclosed net income attributable to parent | 2,204 | |||||||
| Net income (loss) attributable to parent: | (1,807) | 1,102 | (926) | (507) | (444) | 68 | (1,034) | |
| Preferred stock dividends and other adjustments | (125) | |||||||
| Other undisclosed net loss available to common stockholders, basic | (50) | (2,156) | (81) | (548) | (65) | (119) | ||
| Net loss available to common stockholders, diluted: | (1,857) | (1,054) | (1,007) | (1,055) | (509) | (51) | (1,159) | |
Comprehensive Income ($ in thousands)Annual | Quarterly
| 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (1,807) | (1,102) | (926) | (507) | (444) | 68 | (1,034) | |
| Comprehensive income (loss), net of tax, attributable to parent: | (1,807) | (1,102) | (926) | (507) | (444) | 68 | (1,034) | |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.